市場調查報告書
商品編碼
1521120
2024-2032 年依照明設備類型(發光二極體、雷射)、應用、最終用戶和地區分類的光遺傳學市場報告Optogenetics Market Report by Light Equipment Type (Light-emitting Diode, Laser), Application, End User, and Region 2024-2032 |
IMARC Group年全球光遺傳學市場規模達448億美元。
光遺傳學是指結合遺傳學和光學技術的科學方法。它主要用於透過光感測器控制和監測神經元和其他類型細胞的生物功能。這些資訊提供了對個人行為和生理學的深入了解,包括運動、學習、記憶、導航、新陳代謝、呼吸和感測器處理。光遺傳學透過揭示與各種疾病相關的細胞活動來幫助臨床發現,例如慢性疼痛、癲癇、帕金森氏症、中風、毒癮、強迫症(OCD)、社交功能障礙以及焦慮和憂鬱。由於這些應用,光遺傳學在神經科學領域中得到了廣泛的應用。
由於各種感染、疾病、遺傳性疾病、先天性異常以及大腦、神經和脊髓損傷而導致的神經系統疾病的盛行率不斷增加,是目前推動光遺傳學市場成長的關鍵因素之一。與此一致的是,引入光纖耦合發光二極體 (LED) 併入植入物中以實現不受束縛的光傳輸,這是另一個主要的生長誘導因素。此外,神經連接、無線微晶片、感測器、細胞表現型分析工具和各種影像工具(如電腦斷層掃描(CT)、位置發射斷層掃描(PET) 和磁振造影(MRI))的快速技術進步可精確評估器官和組織識別疾病正在推動市場成長。由於其細胞、空間和時間精度,醫療保健專業人員越來越傾向於光遺傳學治療方法,這進一步促進了市場的成長。其他因素包括醫療保健支出的增加、神經科學領域廣泛的研發(R&D)活動,以及主要參與者、製藥公司和各國政府之間的戰略合作,以實施支持推出治療新藥的有利政策神經系統疾病正在為市場創造積極的前景。
The global optogenetics market size reached US$ 44.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 158.7 Billion by 2032, exhibiting a growth rate (CAGR) of 14.8% during 2024-2032.
Optogenetics refers to a scientific approach that includes a combination of genetics and optics technologies. It is primarily used for controlling and monitoring the biological functions of neurons and other types of cells with light sensors. This information provides insights into individual behavior and physiology, including movement, learning, memory, navigation, metabolism, respiration, and sensor processing. Optogenetics aids in clinical discoveries by shedding light on the cellular activities associated with various diseases, such as chronic pain, epilepsy, Parkinson disease, stroke, drug addiction, obsessive compulsion disorder (OCD), social dysfunction, and anxiety and depression. On account of these applications, optogenetics finds extensive utilization in the field of neurosciences.
The increasing prevalence of neurological disorders due to various infections, ailments, genetic disorders, congenital abnormalities, and brain, nerve, and spinal cord injuries is one of the key factors currently driving the optogenetics market growth. In line with this, the introduction of fiber-coupled light-emitting diode (LED) for being incorporated into the implants to enable the untethered light delivery is acting as another major growth-inducing factor. Additionally, rapid technological advancements in neural connectivity, wireless microchip, sensors, cell phenotyping tools, and various imaging tools, like computed tomography (CT), position emission tomography (PET), and magnetic resonance imaging (MRI) to precisely evaluate organs and tissues for identifying disorders is propelling the market growth. The rising inclination of healthcare professionals toward optogenetic therapeutic methodologies on account of its cellular, spatial, and temporal precision is further contributing to the market growth. Other factors, including increasing healthcare expenditure, extensive research and development (R&D) activities in the field of neurosciences, and strategic collaborations between key players, pharmaceutical companies, and governments of various nations to implement favorable policies that support the launch of novel drugs for treating neurological diseases, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global optogenetics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on light equipment type, application and end user.
Light-emitting Diode (LED)
Laser
Neuroscience
Behavioral Tracking
Retinal Disease Treatment
Others
Hospitals
Clinics
Diagnostic
Research
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Addgene, Coherent Inc., Elliot Scientific Limited, GenSight Biologics S.A., HUBNER GmbH & Co KG, Judges Scientific plc, Laserglow Technologies, Noldus Information Technology, Regenxbio Inc., Shanghai Laser & Optics Century Co. Ltd, The Jackson Laboratory and Thorlabs Inc.